Open Letter by U.S. Doctors: JAMA Anti-Ivermectin Study Is Misleading and Fatally Flawed
14/04/2021 No Comments
The severe weaknesses of this study make it uninformative about whether ivermectin is beneficial in early COVID-19 treatment. Yet, the authors misleadingly conclude that their findings “do not support the use of ivermectin for treatment of mild COVID-19”, as if they had enough quality data to make that case, which they do not.